epsilon-amino-caproic acid in the treatment of menorrhagia
Other
OA: green
CC0
AI-generated summary
Epsilon-amino-caproic acid significantly reduced the number of bleeding days and severity in 38 patients with menorrhagia while proving safe and effective.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Epsilon-amino-caproic acid was used in 38 cases of menor-rhagia. In each patient details of bleeding were recorded for four consecutive menstrual periods. Drug was given during two alter-nate periods and the remaining two periods were considered as control periods. Number of days of bleeding and severity of bleed-ing were statistically significantly reduced by epsilon-amino-caproic acid. The drug was found to be safe and effective.
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:58:02.984372+00:00
License: CC0
· commercial use OK